List of Figures
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Pulmonary Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Pulmonary Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Pulmonary Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Pulmonary Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Proportion of Pulmonary Inflammation to Respiratory Clinical Trials, G7 Countries (%), 2018* 12
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Phase (%), 2018* 15
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 16
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2018* 17
Pulmonary Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2018* 18
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 19
Pulmonary Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 20
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 21
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 22
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23
GlobalData Methodology 37


List of Tables
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Region, 2018* 6
Pulmonary Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Pulmonary Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Pulmonary Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Pulmonary Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Proportion of Pulmonary Inflammation to Respiratory Clinical Trials, G7 Countries (%), 2018* 12
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Phase, 2018* 15
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 16
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2018* 17
Pulmonary Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2018* 18
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 19
Pulmonary Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 20
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 21
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 22
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23